Glutamatergic neurotransmission is controlled by presynaptic metabotropic glutamate receptors (mGluRs). A subdomain in the intracellular carboxyl-terminal tail of group III mGluRs binds calmodulin and heterotrimeric guanosine triphosphate–binding protein (G protein) βγ subunits in a mutually exclusive manner. Mutations interfering with calmodulin binding and calmodulin antagonists inhibit G protein–mediated modulation of ionic currents by mGluR 7. Calmodulin antagonists also prevent inhibition of excitatory neurotransmission via presynaptic mGluRs. These results reveal a novel mechanism of presynaptic modulation in which Ca 2+ -calmodulin is required to release G protein βγ subunits from the C-tail of group III mGluRs in order to mediate glutamatergic autoinhibition.
Signaling by D2-dopamine receptors in neurons likely proceeds in the presence of Ca2+ oscillations. We describe here the biochemical basis for a cross-talk between intracellular Ca2+ and the D2 receptor. By activation of calmodulin (CaM), Ca2+ directly inhibits the D2 receptor; this conclusion is based on the following observations: (i) The receptor contains a CaM-binding motif in the NH2-terminal end of the third loop, a domain involved in activating Gi/o. A peptide fragment encompassing this domain (D2N) bound dansylated CaM in a Ca2+-dependent manner (KD ∼ 0.1 μm). (ii) Activation of purified Gαi1 by D2N, and D2receptor-promoted GTPγS (guanosine 5′-(3-O-thio)triphosphate) binding in membranes was suppressed by Ca2+/CaM (IC50 ∼ 0.1 μm). (iii) If Ca2+ influx was elicited in D2 receptor-expressing HEK293 cells, agonist-dependent inhibition of cAMP formation decreased. This effect was not seen with other Gi-coupled receptors (A1-adenosine and Mel1A-melatonin receptor). (iv) The D2 receptor was retained by immobilized CaM and radiolabeled CaM was co-immunoprecipitated with the receptor. Specifically, inhibition by CaM does not result from uncoupling the D2 receptor from its cognate G protein(s); rather, CaM directly targets the D2 receptor to block the receptor-operated G protein activation switch.
Many membrane proteins incur a folding problem during biosynthesis; only a fraction thereof is exported from the endoplasmic reticulum (ER), because quality control is stringent. This is also true for G protein-coupled receptors. Here, we identify the deubiquitinating enzyme Usp4 as an interaction partner of the A2a adenosine receptor, a Gs-coupled receptor. Usp4 binds to the carboxyl terminus of the A2A receptor and allows for its accumulation as deubiquinated protein. This relaxes ER quality control and enhances cell surface expression of functionally active receptor. The effect of Usp4 on the A2A receptor was specific because 1) it was not seen in C-terminally truncated versions of the receptor; 2) it was not mimicked by Usp14, another member of the ubiquitin-specific protease family; and 3) it was not seen with the metabotropic glutamate receptor-5, another G protein-coupled receptor with a high propensity for intracellular retention. These observations show that deubiquinating enzymes can regulate quality control in the ER.
If stably expressed in human embryonic kidney (HEK)293 cells, the human Mel1a-melatonin receptor activates Gi-dependent, pertussis toxin-sensitive signaling pathways, i.e., inhibition of adenylyl cyclase and stimulation of phospholipase Cβ; the latter on condition that Gq is coactivated. The antagonist luzindole blocks the effects of melatonin and acts as an inverse agonist at the Mel1a receptor in both intact cells and isolated membranes. This suggests that the Mel1areceptor is endowed with constitutive activity, a finding confirmed on reconstitution of the Mel1a receptor with Gi. Because the receptor density is in the physiological range, constitutive activity is not an artifact arising from overexpression of the receptor. In addition, the following findings indicate that the Mel1a receptor forms a very tight complex with Gi which can be observed both in the presence and absence of an agonist. 1) In intact cells and in membranes, high-affinity agonist binding is resistant to the destabilizing effect of guanine nucleotides. 2) The ability to bind an agonist with high affinity is preserved even after exposure of the cells to pertussis toxin, because a fraction of Gi is inaccessible to the toxin in cells expressing Mel1a receptors (but not the A1-adenosine receptor, another Gi-coupled receptor). 3) An antiserum directed against the Mel1areceptor coprecipitates Gi even in the absence of an agonist. We therefore conclude that the Mel1a receptor is tightly precoupled and that its constitutive activity may play a role in pacing the biological clock, an action known to involve the melatonin receptors in the suprachiasmatic nucleus.